セルベースアッセイおよびハイコンテントスクリーニングの世界市場：ユーザー別、製品別予測 - エグゼクティブコンサルタントガイド付き（2025年～2029年）

セルベースアッセイは医薬品開発と科学研究の柱であり、パンデミック後の現在、研究活動は回復しつつあります。その上、新技術によってセルベースアッセイは細胞機能のあらゆる側面の測定に使用できるようになっています。この市場はとどまることなく成長を続けています。製薬業界の主力製品は、バイオテクノロジーの中心的存在になりつつあります。

当レポートは、世界のセルベースアッセイおよびハイコンテントスクリーニング市場について調査し、市場の概要とともに、ユーザー別、製品別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

• セルベースアッセイとは何か
• 臨床試験の失敗
• 感染症がより大きな役割を果たす
• 市場の定義
• 調査手法
• 米国の医療市場と医薬品調査費- 見通し

第3章 セルベースアッセイ-技術ガイド

• 細胞培養
• 細胞アッセイ
• 細胞生存率アッセイ
• 細胞増殖アッセイ
• 細胞毒性アッセイ
• 細胞老化アッセイ
• アポトーシス
• オートファジー
• 壊死
• 酸化ストレス
• 2D対3D
• シグナル伝達経路、GPCR
• 免疫調節と抑制
• レポーター遺伝子技術
• CBA設計・開発
• セルベースアッセイ- 要点

第4章 業界の概要

• 市場参入機関
  • 学術研究機関
  • CRO
  • ゲノム機器サプライヤー
  • 細胞分離および観察サプライヤー
  • 細胞株および試薬サプライヤー
  • 製薬会社
  • 監査機関
  • 認証機関

第5章 市場動向

• 成長促進要因
• 成長抑制要因
• 技術開発

第6章 セルベースアッセイの最近の動向

第7章 主要企業のプロファイル

• Abcam
• Agilent
• Aurora Biomed
• Axxam
• Beckman Coulter Diagnostics
• Becton, Dickinson and Company
• Berkley Lights
• BioIVT
• Bio-Rad Laboratories, Inc.
• BMG Labtech
• Bruker
• Cell Biolabs, Inc.
• Cell Signaling Technology, Inc.
• Charles River Laboratories
• Corning, Inc.
• Cytek Biosciences
• Cytovale
• Deepcell
• Enzo Biochem
• Eurofins DiscoverX Corporation
• Evotec AG
• Excellerate Bioscience
• Fujifilm Cellular Dynamics International
• Genedata
• Hemogenix
• Invivogen
• Leica Biosystems
• Lonza Group Ltd.
• Luminex Corp（DiaSorin）
• Merck & Co., Inc
• Miltenyi Biotec
• Molecular Devices
• Nanion
• Ncardia
• New England Biolabs, Inc.
• Novogene Bioinformatics Technology Co., Ltd.
• Olympus
• Origene Technologies
• Promega
• Qiagen
• Reaction Biology
• Recursion Pharma
• Revvity
• Roche Diagnostics
• Sartorius
• Sartorius-ForteBio
• Sartorius-IntelliCyt
• Singleron Biotechnologies
• Sony Biotechnology
• SPT Labtech
• Stemcells Technologies Canada Inc.
• Tecan
• Thermo Fisher Scientific Inc.
• Vitro Biopharma

第8章 世界の市場規模

• 世界市場概要、国別
• 世界市場概要、ユーザー別
• 世界市場概要、製品別

第9章 世界市場、ユーザー別

• 製薬会社
• 研究機関
• 産業/化粧品

第10章 セルベースアッセイ、製品別

• 機器
• 試薬
• サービス
• ソフトウェア

第11章 付録

Table of Tables

• Table 1: The Large Variety of Cell Lines
• Table 2: Some Common Viability Assays
• Table 3: Oxidative Stress Related Diseases
• Table 4: Important Signalling Pathways
• Table 5: Market Players by Type
• Table 6: Five Factors Driving Growth
• Table 7: Three Factors Limiting Growth
• Table 8 - Global Market by Region
• Table 9: Global Market by User
• Table 10: Global Market by Product Class
• Table 11: Pharma by Country
• Table 12: Research by Country
• Table 13: Industry/Cosmetic by Country
• Table 14: Instrument by Country
• Table 15: Reagent by Country
• Table 16: Services by Country
• Table 17: Software by Country

Table of Figures

• Figure 1: Reasons for clinical Failure by Phase
• Figure 2: Immunotherapy Clinical Trial Growth
• Figure 3: Pharmaceutical Research Expenditures ($Billion)
• Figure 4: Oxidative Stress and Free Radical Toxicity
• Figure 5: FDA Cancer Drug Approvals
• Figure 6: The Changing Approach to Cancer Diagnostics
• Figure 7: Growth rates of Cell Based Assays by Product Class
• Figure 8: Global Market Share Chart
• Figure 9: Global Market by User - Base vs. End Year
• Figure 10: Global Market by User Base Year
• Figure 11: Global Market by User End Year
• Figure 12: User Share by Year
• Figure 13: Global Market by Product Class - Base vs. End Year
• Figure 14: Global Market by Product Class Base Year
• Figure 15: Global Market by Product Class End Year
• Figure 16: Product Class Share by Year
• Figure 17: Pharma Growth
• Figure 18: Research Growth
• Figure 19: Industry/Cosmetic Growth
• Figure 20: Instrument Growth
• Figure 21: Reagent Growth
• Figure 22: Services Growth
• Figure 23: Software Growth
• Figure 24: FDA Cancer Drug Approvals by Year
• Figure 25: Clinical Trials for Immunotherapy by Year
• Figure 26: Share of Pharma R&D by Country

Report Overview:

Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is rebounding. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

• 2.1. What are Cell Based Assays?
• 2.2. Clinical Trial Failures
  • 2.2.1. Immuno-oncology Plays a Leading Role in Cell Based Assays
• 2.3. Infectious Disease Will Play a Larger Role
• 2.4. Market Definition
  • 2.4.1. Market Size
  • 2.4.2. Currency
  • 2.4.3. Years
• 2.5. Methodology
  • 2.5.1. Methodology
  • 2.5.2. Sources
  • 2.5.3. Authors
• 2.6. U.S. Medical Market and Pharmceutical Research Spending - Perspective
  • 1.5.1. U.S. Expenditures for Pharmaceutical Research

3. Cell Based Assays - Guide to Technology

• 3.1. Cell Cultures
  • 3.1.1. Cell Lines
  • 3.1.2. Primary Cells
  • 3.1.3. Stem Cells
  • 3.1.4. iPSC's - The Special Case
• 3.2. Cell Assays
• 3.3. Cell Viability Assays
• 3.4. Cell Proliferation Assays
• 3.5. Cytotoxicity Assays
• 3.6. Cell Senescence Assays
• 3.7. Apoptosis
• 3.8. Autophagy
• 3.9. Necrosis
• 3.10. Oxidative Stress
• 3.11. 2D vs. 3D
• 3.12. Signalling Pathways, GPCR
• 3.13. Immune Regulation & Inhibition
• 3.14. Reporter Gene Technology
• 3.15. CBA Design & Development
• 3.16. Cell Based Assays - The Takeaway

4. Industry Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Contract Research Organization
  • 4.1.3. Genomic Instrumentation Supplier
  • 4.1.4. Cell Separation and Viewing Supplier
  • 4.1.5. Cell Line and Reagent Supplier
  • 4.1.6. Pharmaceutical Company
  • 4.1.7. Audit Body
  • 4.1.8. Certification Body

5. Market Trends

• 5.1. Factors Driving Growth
  • 5.1.1. Candidate Growth
  • 5.1.2. Immuno-oncology
  • 5.1.3. Genomic Blizzard
  • 5.1.4. Technology Convergence
  • 5.1.5. The Insurance Effect
• 5.2. Factors Limiting Growth
  • 5.2.1. CBA Development Challenges
  • 5.2.2. Instrument Integration
  • 5.2.3. Protocols
• 5.3. Technology Development
  • 5.3.1. 3D Assays
  • 5.3.2. Automation
  • 5.3.3. Software
  • 5.3.4. Primary Cells
  • 5.3.5. Signalling and Reporter Genes
  • 5.3.6. The Next Five Years

6. Cell Based Assays Recent Developments

• 6.1. Recent Developments
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. New cell-based Screening Panel
• 6.3. New platform will accelerate single-cell analysis workflow
• 6.4. CytoTronics Announces Pixel Octo
• 6.5. Cell Painting boosts high-throughput screening
• 6.6. Castle Biosciences Sees Big Gains in New Testing Niches
• 6.7. Cell-Based Assay Outperforms Others
• 6.8. 3D spheroid model Monitors T-cell invasion
• 6.9. BioAuxilium Launches New Biomarker Assay
• 6.10. Charles River Laboratories Acquires SAMDI Tech
• 6.11. Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform
• 6.12. Fujifilm's Life Sciences Invests in PhenoVista Biosciences
• 6.13. Nucleai Launches New Multiplex Imaging Spatial Analysis Solution
• 6.14. BIO-TECHNE ANNOUNCES MULTI-OMIC RNASCOPE ASSAYS
• 6.15. Indivumed, CellPhenomics Partner on Cancer Drug Target Research
• 6.16. Synthego to Accelerate Drug Discovery
• 6.17. Long COVID Detected By Cell-Based Assay
• 6.18. Nanolive closes a USD 20 million Funding Round
• 6.19. Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery
• 6.20. BioAuxilium Research Expands its Cell Signaling Assay Portfolio
• 6.21. Droplet Genomics Debuts New Microfluidic Screening Platform
• 6.22. DLP Plus Single-Cell Sequencing Method Spreads From Canada to Cancer Labs Worldwide
• 6.23. Secondcell Bio to Make Creation of Cell Lines Easy
• 6.24. Nanolitre-scale cell assays developed with droplet microarraymass spec
• 6.25. Thermo Fisher Scientific Acquires Cell Sorting Technology
• 6.26. Cellink to Distribute Phasefocus High-Content Cell Imaging Platform
• 6.27. Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
• 6.28. Cancer Genetics to Acquire Organoid Startup Stemonix
• 6.29. Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
• 6.30. CRISPR Screens Uncover Novel Cancer Therapy Targets
• 6.31. ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam

7. Profiles of Key Cell Based Assay Companies

• 7.1. Abcam
• 7.2. Agilent
• 7.3. Aurora Biomed
• 7.4. Axxam
• 7.5. Beckman Coulter Diagnostics
• 7.6. Becton, Dickinson and Company
• 7.7. Berkley Lights
• 7.8. BioIVT
• 7.9. Bio-Rad Laboratories, Inc.
• 7.10. BMG Labtech
• 7.11. Bruker
• 7.12. Cell Biolabs, Inc.
• 7.13. Cell Signaling Technology, Inc.
• 7.14. Charles River Laboratories
• 7.15. Corning, Inc.
• 7.16. Cytek Biosciences
• 7.17. Cytovale
• 7.18. Deepcell
• 7.19. Enzo Biochem
• 7.20. Eurofins DiscoverX Corporation
• 7.21. Evotec AG
• 7.22. Excellerate Bioscience
• 7.23. Fujifilm Cellular Dynamics International
• 7.24. Genedata
• 7.25. Hemogenix
• 7.26. Invivogen
• 7.27. Leica Biosystems
• 7.28. Lonza Group Ltd.
• 7.29. Luminex Corp (DiaSorin)
• 7.30. Merck & Co., Inc
• 7.31. Miltenyi Biotec
• 7.32. Molecular Devices
• 7.33. Nanion
• 7.34. Ncardia
• 7.35. New England Biolabs, Inc.
• 7.36. Novogene Bioinformatics Technology Co., Ltd.
• 7.37. Olympus
• 7.38. Origene Technologies
• 7.39. Promega
• 7.40. Qiagen
• 7.41. Reaction Biology
• 7.42. Recursion Pharma
• 7.43. Revvity
• 7.44. Roche Diagnostics
• 7.45. Sartorius
• 7.46. Sartorius-ForteBio
• 7.47. Sartorius-IntelliCyt
• 7.48. Singleron Biotechnologies
• 7.49. Sony Biotechnology
• 7.50. SPT Labtech
• 7.51. Stemcells Technologies Canada Inc.
• 7.52. Tecan
• 7.53. Thermo Fisher Scientific Inc.
• 7.54. Vitro Biopharma

8. Global Market Size

• 8.1. Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market by User - Overview
  • 8.2.1. Table - Global Market by User
  • 8.2.2. Chart - Global Market by User - Base/End Year Comparison
  • 8.2.3. Chart - Global Market by User - Base Year
  • 8.2.4. Chart - Global Market by User - End Year
  • 8.2.5. Chart - Global Market by User - Share by Year
• 8.3. Global Market by Product Class - Overview
  • 8.3.1. Table - Global Market by Product Class
  • 8.3.2. Chart - Global Market by Product Class - Base/End Year Comparison
  • 8.3.3. Chart - Global Market by Product Class - Base Year
  • 8.3.4. Chart - Global Market by Product Class - End Year
  • 8.3.5. Chart - Global Market by Product Class - Share by Year

9. Global Market by User Type

• 9.1. Pharma
  • 9.1.1. Table Pharma - by Country
  • 9.1.2. Chart - Pharma Growth
• 9.2. Research
  • 9.2.1. Table Research - by Country
  • 9.2.2. Chart - Research Growth
• 9.3. Industry/Cosmetic
  • 9.3.1. Table Industry/Cosmetic - by Country
  • 9.3.2. Chart - Industry/Cosmetic Growth

10. Cell Based Assay by Product Class

• 10.1. Instrument
  • 10.1.1. Table Instrument - by Country
  • 10.1.2. Chart - Instrument Growth
• 10.2. Reagent
  • 10.2.1. Table Reagent - by Country
  • 10.2.2. Chart - Reagent Growth
• 10.3. Services
  • 10.3.1. Table Services - by Country
  • 10.3.2. Chart - Services Growth
• 10.4. Software
  • 10.4.1. Table Software - by Country
  • 10.4.2. Chart - Software Growth

11. Appendices

• 11.1. FDA Cancer Drug Approvals by Year
• 11.2. Clinical Trials Started
• 11.3. Share of Pharma R&D by Country